Physiologically Based Pharmacokinetic Modeling of Small Molecules: How Much Progress Have We Made?

N Isoherranen - Drug Metabolism and Disposition, 2024 - Elsevier
Physiologically based pharmacokinetic (PBPK) models of small molecules have become
mainstream in drug development and in academic research. The use of PBPK models is …

Lessons learned to boost a bioinformatics knowledge base reusability, the Bgee experience

T Mendes de Farias, J Wollbrett… - …, 2023 - academic.oup.com
Background Enhancing interoperability of bioinformatics knowledge bases is a high-priority
requirement to maximize data reusability and thus increase their utility such as the return on …

Physiologically based pharmacokinetic models for systemic disposition of protein therapeutics in rabbits

RK Jairam, M Franz, N Hanke, L Kuepfer - Frontiers in Pharmacology, 2024 - frontiersin.org
Physiologically based pharmacokinetic (PBPK) modelling is an important tool to predict drug
disposition in the body. Rabbits play a pivotal role as a highly valued small animal model …

Predictions of Bedaquiline Central Nervous System Exposure in Patients with Tuberculosis Meningitis Using Physiologically based Pharmacokinetic Modeling

K Mehta, P Balazki, PH van der Graaf, T Guo… - Clinical …, 2024 - Springer
Abstract Background and Objective The use of bedaquiline as a treatment option for drug-
resistant tuberculosis meningitis (TBM) is of interest to address the increased prevalence of …

The potential impact of CYP and UGT drug-metabolizing enzymes on brain target site drug exposure

M Zhang, V Rottschäfer… - Drug Metabolism …, 2024 - Taylor & Francis
Drug metabolism is one of the critical determinants of drug disposition throughout the body.
While traditionally associated with the liver, recent research has unveiled the presence and …

Insights into pharmacogenetics, drug-gene interactions, and drug-drug-gene interactions

LE Russell, KG Claw, KM Aagaard… - Drug Metabolism …, 2024 - Taylor & Francis
This review explores genetic contributors to drug interactions, known as drug-gene and drug-
drug-gene interactions (DGI and DDGI, respectively). This article is part of a mini-review …

PBPK modeling: What is the role of CYP3A4 expression in the gastrointestinal tract to accurately predict first‐pass metabolism?

J Henriot, A Dallmann, F Dupuis… - CPT …, 2024 - Wiley Online Library
Gastrointestinal first‐pass metabolism plays an important role in bioavailability and in drug–
drug interactions. Physiologically‐based pharmacokinetic (PBPK) modeling is a powerful …

PBPK modeling of recombinant factor IX Fc fusion protein (rFIXFc) and rFIX to characterize the binding to type 4 collagen in the extravascular space

ME Cloesmeijer, E Sjögren… - CPT …, 2024 - Wiley Online Library
Patients with severe and sometimes moderate hemophilia B are prophylactically treated with
factor IX concentrates to prevent bleeding. For some time now, various extended terminal …

[PDF][PDF] Quantitati e pharmacolog approaches to inform treatment strategies against tuberculosis

K Mehta - scholarlypublications …
Aim: Bedaquiline, pretomanid, and linezolid combination (BPaL) treatment against
Mycobacterium tuberculosis is promising yet safety and adherence concerns exist that …